CD4+ T cells mediate cytotoxicity in neurodegenerative diseases

Journal of Clinical Investigation

Volumn 119, Issue 1, 2009, Pages 13-15

  Appel, Stanley H ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; FAS LIGAND; LIPOPOLYSACCHARIDE; DOPAMINE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CYTOTOXICITY; DEGENERATIVE DISEASE; HUMAN; IMMUNE SYSTEM; IMMUNOTHERAPY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MICROGLIA; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NOTE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH1 CELL; TH17 CELL; ANIMAL; APOPTOSIS; ARTICLE; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; METABOLISM; MOUSE; PARKINSONISM; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ALPHA-SYNUCLEIN; ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; DOPAMINE; HUMANS; INFLAMMATION; MICE; MICROGLIA; PARKINSONIAN DISORDERS; T-LYMPHOCYTE SUBSETS;

EID: 61749097003     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38096     Document Type: Note

References (19)

1. Mantovani, A. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677-686.
2. Le, W., et al. 2001. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J. Neurosci. 21:8447-8455.
3. McGeer, P.L., Itagi, S., and Akiyama, H. 1988. Rate of cell death in parkinsonism indicates active neuropathological process. Ann. Neurol. 24:574-576.
4. Langston, J.W., et al. 1999. Evidence of active nerve degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6- tetrahydropyidine exposure. Ann. Neurol. 46:598-605.
5. Liberatore, G., et al. 1999. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5:1403-1409.
6. Wu, D.C., et al. 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyidine mouse model of Parkinson disease. J. Neurosci. 22:1763-1771.
7. Polymeropoulos, M.H., et al. 1997. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:2045-2047.
8. Farrer, M.J., et al. 2004. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann. Neurol. 55:174-179.
9. Martinez-Vicente, M. 2008. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest. 118:777-788.
10. Gao, H.-M., et al. 2008. Neuroinf lammation and oxidation/nitration of α-synuclein linked to dopaminergic neurodegneration. J. Neurosci. 28:7687-7698.
11. + lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 119:182-192.
12. Mount, M.P., et al. 2007. Involvement of interferongamma in microglia-mediated loss of dopaminergic neurons. J. Neurosci. 27:3328-3337.
13. Mosmann, T.R., et al. 1986. Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
14. Park, D.R., et al. 2003. Fas(CD95) induces proinf lammatory cytokine responses by human monocytes and monocyte-derived macrophages. J. Immunol. 170:6209-6216.
15. Kebir, H., et al. 2007. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13:1173-1175.
16. Benner, E.J. 2008. Nitrated α-synuclein immunity accelerates degeneration of nigral dopaminergic neurons. PLoS ONE. 3:e1376.
17. Henkel, J.S., Beers, D.R., Siklos, L., and Appel, S.H. 2006. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol. Cell. Neurosci. 31:427-437.
18. + T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc. Natl. Acad. Sci. U. S. A. 105:15558-15563.
19. Mills, K.H.G. 2008. Induction, function, and regulation of IL-17-producing T cells. Eur. J. Immunol. 38:2636-2649.